Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
Balaji Amines Limited
BALAMINES | NSE
2,173.60
INR-26.10
-1.19%
BALAMINES | NSE
About Balaji Amines Limited
Sector
Basic Materials
Industry
Specialty Chemicals
Earnings date
31/03/2024
As of date
18/10/2024
Close
2,173.60
Open
2,198.00
High
2,200.05
Low
2,157.05
Balaji Amines Limited engages in the manufacture and sale of methylamines ethylamines and derivatives of specialty chemicals and pharma excipients in India. The company operates in two segments Chemicals and Hotel. It offers monomethylamine dimethylamine trimethylamine monoethylamine diethylamine triethylamine and dimethyl and diethyl amino ethanol; and specialty chemicals including N-methyl pyrrolidone morpholine 2-pyrrolidone N-ethyl-2-pyrrolidone gamma-butyrolactone dimethylformamide acetonitrile dimethylcarbonate propylene glycol and propylene carbonate. The company also provides derivatives comprising di-methyl acetamide di-methyl amine hydrochloride tri-methyl amine hydrochloride di-ethyl amine hydrochloride tri-ethyl amine hydrochloride di-methyl urea choline chloride mono-ethyl amine hydrochloride and benzyl tri ethyl ammonium chloride; and pharma excipients such as poly vinyl pyrrolidone. In addition it operates Balaji Sarovar Premiere a hotel in Solapur Maharashtra. The company serves pharmaceutical agrochemical paint and resin animal feed oil and gas rubber cleaning chemical dye and textile and water treatment chemical industries as well as food and beverage fragrance and specialty chemical sectors. It also exports its products to the United States the United Kingdom Argentina Latin America Canada Israel Australia Bangladesh Germany Italy Egypt South Africa and internationally. Balaji Amines Limited was incorporated in 1988 and is headquartered in Solapur India.
View LessBALAMINES | NSE
Risk
29.6
Sharpe
-0.18
Luna's Score
40/100
Recommendation
Sell
Luna says (BALAMINES | NSE)
What's Working
Low Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
What's not Working
Negative Momentum (Declining Price)
Price Below SMA10D
Smallcap (300M - 2B USD)
High Market Beta (> 0.8)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Volatility Signals
Bearish: Increased Volatility (6-month > 1-month volatility)
Risk Meter
10 days
28.3%1 month
29.6%3 months
32.9%6 months
33.2%Returns
Fundamental Ratios
PE
36.10
Fwd. PE
26.67
Price to book
4.14
Debt to equity
0.01
Debt to assets
0.01
Ent. to EBITDA
21.21
Ent. to rev.
4.46
PEG
-
Other Fundamentals
EBITDA
2.94B
MarketCap
70.43B
MarketCap(USD)
848.52M
Div. yield
0.51
Op. margin
14.15
Erngs. growth
-17.90
Rev. growth
-17.00
Ret. on equity
12.94
Short ratio
-
Short perc.
-
Market Sentiment (SMA and Price signals)
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
SMAs: Stock Price Trends
Range10D
146.25
Range1M
302.85
Range3M
460.50
Volumes: Market Activity
Rel. volume
0.32
Price X volume
47.63M
Peers
Diversifiers
Industry Comparison
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 21.21 | 33.04 | Cheaper |
| Ent. to Revenue | 4.46 | 6.32 | Cheaper |
| PE Ratio | 36.10 | 50.17 | Cheaper |
| Price to Book | 4.14 | 5.36 | Cheaper |
| Dividend Yield | 0.51 | 0.61 | Par |
| Std. Deviation (3M) | 32.92 | 41.67 | Lower Risk |
| Debt to Equity | 0.01 | 0.30 | Cheaper |
| Debt to Assets | 0.01 | 0.14 | Cheaper |
| Market Cap | 70.43B | 136.24B | Emerging |
